The Hill: Big Pharma’s lobbyists are losing despite their ‘pass the buck’ campaigns

The Hill: Big Pharma’s lobbyists are losing despite their ‘pass the buck’ campaigns

Their relentless, ongoing PR blitz is simply an effort to pass the buck and direct attention away from their pricing strategies